Login Register Cart 0
Generic placeholder image

Current Psychiatry Research and Reviews

Editor-in-Chief

ISSN (Print): 2666-0822
ISSN (Online): 2666-0830

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Research Article

Omega-3 Fatty Acid Supplementation Improves Attention Deficit-Hyperactivity Disorder Symptoms in Children

Author(s): Uri Yatzkar, Eti Amir, Snait Tamir and Ayelet Armon-Omer*

Volume 20, Issue 1, 2024

Published on: 27 January, 2023

Page: [48 - 58] Pages: 11

DOI: 10.2174/2666082219666230103113402

Price: $65

Abstract

Background: Attention Deficit-Hyperactivity Disorder (ADHD) is one of the most common neuropsychiatric disorders in children. Increasing evidence suggests an association between omega-3 fatty acid and ADHD. We aimed to investigate the effects of 6-month omega- 3 fatty acid supplementation on the fatty-acid profile of erythrocytes and on the clinical severity of ADHD symptoms in children.

Methods: Recruitment included 32 children aged 6-14 years diagnosed with ADHD at the Child and Adolescent Psychiatry Department at Ziv Medical Center, Israel. Intervention included refrigerated omega-3 fatty acid supplementation normalized to body weight. Blood samples were taken at baseline, 3 and 6 months after intervention for quantification of fatty acids from erythrocyte membranes. ADHD symptoms were assessed by parents and teachers according to the ADHD Rating-Scale and the Strengths and Difficulties Questionnaire. ADHD severity was additionally assessed by a psychiatrist according to the Clinical Global Impressions Scale.

Results: Supplementation of omega-3 fatty acid in children with ADHD raised their omega-3 index statistically significantly from an average of 4.4% omega-3 index at baseline to 11.6% after 6 months and had beneficial effects on ADHD symptoms, as measured by validated questionnaires and in accordance with a pediatric psychiatrist examination.

Conclusion: Our pilot study showed that dietary supplementation of omega-3 fatty acid increased the blood omega-3 index levels and improved ADHD symptoms even at the midpoint of 3 months.

« Previous Next »
Graphical Abstract

[1]
Cortese S, Coghill D. Twenty years of research on attention-deficit/hyperactivity disorder (ADHD): Looking back, looking forward. Evid Based Ment Health 2018; 21(4): 173-6.
[http://dx.doi.org/10.1136/ebmental-2018-300050] [PMID: 30301823]
[2]
Park H, Hong J, Park B, Cho H. Age-related connectivity differences between attention deficit and hyperactivity disorder patients and typically developing subjects: A resting-state functional MRI study. Neural Regen Res 2017; 12(10): 1640-7.
[http://dx.doi.org/10.4103/1673-5374.217339] [PMID: 29171429]
[3]
Chang JPC, Su KP. Nutritional neuroscience as mainstream of psychiatry: The evidence- based treatment guidelines for using omega-3 fatty acids as a new treatment for psychiatric disorders in children and adolescents. Clin Psychopharmacol Neurosci 2020; 18(4): 469-83.
[http://dx.doi.org/10.9758/cpn.2020.18.4.469] [PMID: 33124582]
[4]
Sastry PS. Lipids of nervous tissue: Composition and metabolism. Prog Lipid Res 1985; 24(2): 69-176.
[http://dx.doi.org/10.1016/0163-7827(85)90011-6] [PMID: 3916238]
[5]
Calder PC. Mechanisms of action of (n-3) fatty acids. J Nutr 2012; 142(3): 592S-9S.
[http://dx.doi.org/10.3945/jn.111.155259] [PMID: 22279140]
[6]
Melo HM, Santos LE, Ferreira ST. Diet-derived fatty acids, brain inflammation, and mental health. Front Neurosci 2019; 13: 265.
[http://dx.doi.org/10.3389/fnins.2019.00265] [PMID: 30983955]
[7]
Chanda W, Joseph TP, Guo X, et al. Effectiveness of omega-3 polyunsaturated fatty acids against microbial pathogens. J Zhejiang Univ Sci B 2018; 19(4): 253-62.
[http://dx.doi.org/10.1631/jzus.B1700063] [PMID: 29616501]
[8]
Tribulova N, Szeiffova Bacova B, Egan Benova T, Knezl V, Barancik M, Slezak J. Omega-3 index and anti-arrhythmic potential of omega-3 PUFAs. Nutrients 2017; 9(11): 1191.
[http://dx.doi.org/10.3390/nu9111191] [PMID: 29084142]
[9]
Golanski J, Szymanska P, Rozalski M. Effects of omega-3 polyunsaturated fatty acids and their metabolites on haemostasis-current perspectives in cardiovascular disease. Int J Mol Sci 2021; 22(5): 2394.
[http://dx.doi.org/10.3390/ijms22052394] [PMID: 33673634]
[10]
Mariamenatu AH, Abdu EM. Overconsumption of Omega-6 Polyunsaturated Fatty Acids (PUFAs) versus deficiency of omega-3 PUFAs in modern-day diets: The disturbing factor for their “balanced antagonistic metabolic functions” in the human body. J Lipids 2021; 2021: 1-15.
[http://dx.doi.org/10.1155/2021/8848161] [PMID: 33815845]
[11]
Weiser M, Butt C, Mohajeri M. Docosahexaenoic acid and cognition throughout the lifespan. Nutrients 2016; 8(2): 99.
[http://dx.doi.org/10.3390/nu8020099] [PMID: 26901223]
[12]
Larqué E, Pagán A, Prieto MT, et al. Placental fatty acid transfer: A key factor in fetal growth. Ann Nutr Metab 2014; 64(3-4): 247-53.
[http://dx.doi.org/10.1159/000365028] [PMID: 25300267]
[13]
Umhau JC, Zhou W, Carson RE, et al. Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography. J Lipid Res 2009; 50(7): 1259-68.
[http://dx.doi.org/10.1194/jlr.M800530-JLR200] [PMID: 19112173]
[14]
Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003; 143(4) (Suppl.): 1-8.
[http://dx.doi.org/10.1067/S0022-3476(03)00396-2] [PMID: 14597908]
[15]
Harris WS, von Schacky C. The Omega-3 Index: A new risk factor for death from coronary heart disease? Prev Med 2004; 39(1): 212-20.
[http://dx.doi.org/10.1016/j.ypmed.2004.02.030] [PMID: 15208005]
[16]
Milte CM, Sinn N, Howe PRC. Polyunsaturated fatty acid status in attention deficit hyperactivity disorder, depression, and Alzheimer’s disease: Towards an omega-3 index for mental health? Nutr Rev 2009; 67(10): 573-90.
[http://dx.doi.org/10.1111/j.1753-4887.2009.00229.x] [PMID: 19785689]
[17]
Stevens LJ, Zentall SS, Deck JL, et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am J Clin Nutr 1995; 62(4): 761-8.
[http://dx.doi.org/10.1093/ajcn/62.4.761] [PMID: 7572706]
[18]
Yamamoto N, Hashimoto A, Takemoto Y, et al. Effect of the dietary alpha-linolenate/linoleate balance on lipid compositions and learning ability of rats. II. Discrimination process, extinction process, and glycolipid compositions. J Lipid Res 1988; 29(8): 1013-21.
[http://dx.doi.org/10.1016/S0022-2275(20)38463-7] [PMID: 2903207]
[19]
LaChance L, McKenzie K, Taylor VH, Vigod SN. Omega-6 to omega-3 fatty acid ratio in patients with ADHD: A meta-analysis. J Can Acad Child Adolesc Psychiatry 2016; 25(2): 87-96.
[20]
Sorgi PJ, Hallowell EM, Hutchins HL, Sears B. Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder. Nutr J 2007; 6(1): 16.
[http://dx.doi.org/10.1186/1475-2891-6-16] [PMID: 17629918]
[21]
Burgess JR, Stevens L, Zhang W, Peck L. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder. Am J Clin Nutr 2000; 71(1) (Suppl.): 327S-30S.
[http://dx.doi.org/10.1093/ajcn/71.1.327S] [PMID: 10617991]
[22]
Armon-Omer A, Amir E, Neuman H, et al. Unique trans-fatty acid profile in children with attention deficit hyperactivity disorder. Front Psychiatry 2021; 12: 740169.
[http://dx.doi.org/10.3389/fpsyt.2021.740169] [PMID: 34803763]
[23]
van der Wurff ISM, Meyer BJ, de Groot RHM. Effect of omega-3 Long Chain Polyunsaturated Fatty Acids (n-3 LCPUFA) supplementation on cognition in children and adolescents: A systematic literature review with a focus on n-3 LCPUFA blood values and dose of DHA and EPA. Nutrients 2020; 12(10): 3115.
[http://dx.doi.org/10.3390/nu12103115] [PMID: 33053843]
[24]
Händel MN, Rohde JF, Rimestad ML, et al. Efficacy and safety of polyunsaturated fatty acids supplementation in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: A systematic review and meta-analysis of clinical trials. Nutrients 2021; 13(4): 1226.
[http://dx.doi.org/10.3390/nu13041226] [PMID: 33917727]
[25]
APA. Diagnostic and statistical manual of mental disorders fifth edition dsm-5TM. Washington, DC; London, England: American Psychiatric Association 2013.
[26]
Agostoni C, Nobile M, Ciappolino V, et al. The role of omega-3 fatty acids in developmental psychopathology: A systematic review on early psychosis, autism, and ADHD. Int J Mol Sci 2017; 18(12): 2608.
[http://dx.doi.org/10.3390/ijms18122608] [PMID: 29207548]
[27]
Busner J, Targum SD. The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont) 2007; 4(7): 28-37.
[PMID: 20526405]
[28]
DuPaul GJ, Reid R, Anastopoulos AD, Lambert MC, Watkins MW, Power TJ. Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: Factor structure and normative data. Psychol Assess 2016; 28(2): 214-25.
[http://dx.doi.org/10.1037/pas0000166] [PMID: 26011476]
[29]
Goodman R. The strengths and difficulties questionnaire: A research note. J Child Psychol Psychiatry 1997; 38(5): 581-6.
[http://dx.doi.org/10.1111/j.1469-7610.1997.tb01545.x] [PMID: 9255702]
[30]
Mansbach-Kleinfeld I, Apter A, Farbstein I, Levine SZ, Ponizovsky AM. A population-based psychometric validation study of the strengths and difficulties questionnaire - hebrew version. Front Psychiatry 2010; 1: 151.
[http://dx.doi.org/10.3389/fpsyt.2010.00151] [PMID: 21423458]
[31]
Witte AV, Kerti L, Hermannstädter HM, et al. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb Cortex 2014; 24(11): 3059-68.
[http://dx.doi.org/10.1093/cercor/bht163] [PMID: 23796946]
[32]
Wendell SG, Baffi C, Holguin F. Fatty acids, inflammation, and asthma. J Allergy Clin Immunol 2014; 133(5): 1255-64.
[http://dx.doi.org/10.1016/j.jaci.2013.12.1087] [PMID: 24613565]
[33]
Wilczynska-Kwiatek A, Bargiel-Matusiewicz K, Lapinski L. Asthma, allergy, mood disorders, and nutrition. Eur J Med Res 2009; 14 (Suppl. 4): 248-54.
[http://dx.doi.org/10.1186/2047-783X-14-S4-248] [PMID: 20156766]
[34]
Hibbeln JR. Fish consumption and major depression. Lancet 1998; 351(9110): 1213.
[http://dx.doi.org/10.1016/S0140-6736(05)79168-6] [PMID: 9643729]
[35]
Chang JPC, Su KP, Mondelli V, et al. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Transl Psychiatry 2019; 9(1): 303.
[http://dx.doi.org/10.1038/s41398-019-0633-0] [PMID: 31745072]
[36]
Armon-Omer A, Waldman C, Simaan N, Neuman H, Tamir S, Shahien R. New insights on the nutrition status and antioxidant capacity in multiple sclerosis patients. Nutrients 2019; 11(2): 427.
[http://dx.doi.org/10.3390/nu11020427] [PMID: 30781687]
[37]
Coghill D, Spiel G, Baldursson G, et al. Which factors impact on clinician-rated impairment in children with ADHD? Eur Child Adolesc Psychiatry 2006; 15(S1) (Suppl. 1): i30-7.
[http://dx.doi.org/10.1007/s00787-006-1005-x] [PMID: 17177013]
[38]
Collett BR, Ohan JL, Myers KM. Ten-year review of rating scales. V: Scales assessing attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 2003; 42(9): 1015-37.
[http://dx.doi.org/10.1097/01.CHI.0000070245.24125.B6] [PMID: 12960702]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy